Zaleplon Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 5 mg, 10 mg
Reference Brands: Sonata (USA/EU), Starnoc (EU)
Category:
Sleep Disorders
Zaleplon is available in Capsules
and strengths such as 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Zaleplon is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Zaleplon can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Insomnia is a common sleep disorder that becomes increasingly prevalent with advancing age. A significant proportion of elderly individuals experience difficulty initiating sleep, frequent awakenings during the night, and dissatisfaction with overall sleep quality. These disturbances often lead to daytime symptoms such as fatigue, drowsiness, reduced concentration, and impaired daily functioning, ultimately affecting quality of life. Changes in lifestyle, medical conditions, psychiatric disorders, and social factors can all contribute to sleep problems in older adults. In many cases, insomnia in this population is multifactorial and requires careful evaluation to identify underlying causes.
Management of insomnia in elderly patients typically begins with addressing contributing physical or psychological conditions and improving sleep hygiene practices, such as maintaining regular sleep schedules and reducing stimulants before bedtime. When these measures are not sufficient, treatment with appropriate hypnotic medications may be considered under medical supervision. These therapies can help improve sleep initiation, maintain sleep continuity, and enhance overall sleep quality. With proper assessment and treatment, insomnia can be effectively managed, supporting better daily functioning and overall well-being in older individuals.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing